Bristol-Myers Squibb Company Stock Price Analysis

Recent Analyst Estimates and Earnings Update

Analysts are revising their estimates for Bristol-Myers Squibb Company (BMY) following the company's recent earnings report. Several analysts have upgraded their per-share earnings (EPS) estimates for both the current quarter and the full year.

Earnings and Revenue Upgrades

According to Refinitiv data, the average EPS estimate for the current quarter has been raised to $1.91 from $1.87 previously. The full-year EPS estimate has also been revised upwards to $8.97 from $8.86.

In addition, analysts are predicting stronger-than-expected revenue growth for BMY. The average revenue estimate for the current quarter has been increased to $12.9 billion, while the full-year revenue estimate has been lifted to $50.7 billion.

Market Reaction

The positive analyst estimates have boosted investor sentiment towards BMY stock. In recent trading, the stock has gained over 2%, pushing it to a new 52-week high.